Josh Pyke on anxiety and panic attacks: ‘I was worried medication would affect my creativity

The singer-songwriter took a two-year break from touring to address his mental health – then the pandemic hit. So how does he feel hitting the road again?

Brigid Delaney

Fri 18 Mar 2022 19.00 GMT

So many lockdown albums carry with them the echoes of confinement – but not Josh Pyke’s latest release, To Find Happiness. The songs are infused with the vibe of lying in a field on a summer’s day, being warmed by the sun. It’s sweet, expansive and lovely, about finding moments of happiness in everyday life.

After a long hiatus, Pyke is keen to get back on the road to play it for crowds: his struggles with anxiety saw him take a two-year break from touring before the pandemic. When he finally felt well enough, Covid hit and the lockdowns began. It is reminiscent of what happened to US performer Bo Burnham, who took five years off to deal with his severe panic attacks before preparing to tour in March 2020 – just as everything was shut down.

Study shows anxiety and depression in children of color tripled amid the pandemic - ABC10

ABC10

UC Davis Health Child and Adolescent Psychiatrist Dr. Anu Gupta explained the research behind this study. She said there are psychosocial risks some ...

Marcar como no importante

Study suggests fiber helps protect people from melanoma - YouTube

YouTube

Today's HealthCAST features information about the findings of a study on the benefits of fiber.

Marcar como no importante

Olivia Munn Talks 'Horrible' Postpartum Anxiety After Son's Birth - Us Weekly

Us Weekly

Olivia Munn Gets Real About 'Horrible' Postpartum Anxiety 3 Months After Son ... Jade Roper, More Celeb Moms Share Postpartum Depression, Anxiety ...

Marcar como no importante

Comments

Exploring the Link Between Circadian Rhythms, Longevity, and Wearable Data: Insights and Future Directions

A recent study in NHANES 2011–2014 explores the potential connection between disruptions in circadian rhythms, measured using wearable devices, and their impact on health outcomes and longevity. The study analyzes data from 7,297 U.S. adults collected through wearable accelerometers as a novel digital biomarker for longevity. Five distinct clusters were identified based on activity profiles: "High activity," "Low activity," "Mild circadian rhythm (CR) disruption," "Severe CR disruption," and "Very low activity." The findings reveal that young adults with extreme circadian rhythm disturbance exhibit higher white blood cell counts and accelerated biological aging. Older adults with circadian disruption are associated with increased systemic inflammation indexes, advanced biological aging, and higher all-cause mortality risk. The research underscores the importance of circadian alignment for longevity at all ages and suggests that wearable

The safety of aspartame is under review by WHO after conflicting findings.

Aspartame, a sweetener with health effects Since 1981, the WHO expert committee on additives has confirmed the safety of aspartame consumption within acceptable daily limits. The international organization has established that the acceptable daily intake (ADI) of aspartame is 40 milligrams per kilogram of body weight. This means that a person can consume up to 40 mg of aspartame per kilogram of their body weight per day without risking their health. For example, if someone weighs 60 kilos, the allowable amount of aspartame would be 2,400 milligrams (40 mg/kg x 60 kg). In recent years, several studies have been carried out on the effects of aspartame on health. The Food and Drug Administration (FDA) has reviewed the scientific evidence related to the safety of this sweetener five times since its approval in 1981, and has concluded that it remains safe for use. However, it is being studied again. It has an especially important use in low-calorie beverages consumed by children and pregnan

Light Therapy holds promise as a treatment for Alzheimer's Disease

A new article, conducted by Lili Zang and colleagues from Weifang Medical University School of Nursing in Shandong Province, China, discusses a meta-analysis of 15 high-quality trials that investigated the impact of light therapy on individuals with Alzheimer’s disease (AD). The meta-analysis included 598 patients with mild to moderate Alzheimer’s disease, and it covered 15 randomized controlled trials conducted in seven different countries. Those trials were published between 2005 and 2022. Sleep Improvement Light therapy led to significant improvements in several sleep measures. It notably enhanced sleep efficiency, increased interdaily stability, and reduced intradaily variability, all of which are indicators of better sleep quality. Light therapy was associated with a reduction in agitation, depression, and caregiver burden among individuals with Alzheimer’s disease. A significant advantage over usual care was shown in reducing the severity of psychobehavioral symptoms, as assessed

Wellness-uptodate

Search This Blog